The 3rd Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit covers topics such as:
- Adenosine’s Role in IO – How Clinical Progress in Adenosine is Shaping the Future of Immunotherapy
- Clinical Development Challenges & Rational Strategies For More a Confident Approach to Clinical Trials
- Preclinical Modeling In Vivo, In Vitro & Ex Vivo for Confident Clinical Translation of Adenosine Targeted Therapeutics
- CD73/CD39 Understanding Biological Principles & Concepts to Enable Fast Development
- Exploring Adenosine Receptor Biology & Taking Advantage of its Strengths
The 3rd Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit might be held in Boston, United States in 2024.
